Trial intelligence / Profile preview

Metformin for diabetes prevention in adults with HIV and prediabetes in Tanzania

ISRCTN77382043Phase 3Completed

Sponsor
University College London
Start
Oct 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in prediabetes comparing Metformin extended-release with Matching placebo (2 arms). Primary endpoint: Incidence of diabetes. Started Oct 2021; status: completed.

02

Drugs

metformin
03

Conditions

prediabetes

Beyond the preview

Go deeper on ISRCTN77382043.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ISRCTN77382043.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call